Akouos - Ownership and Business Overview

Life ScienceCompany

Akouos Ownership

Who owns Akouos?

Akouos is owned by Eli Lilly. It was acquired on October 18, 2022.

Akouos Business Overview

Where is Akouos headquartered?

Akouos is headquartered in Boston, Massachusetts.

How many employees does Akouos have?

Akouos has 103 employees.

What sector is Akouos in?

Akouos is a life science company.

When was Akouos founded?

Akouos was founded in 2016.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 288 acquisitions of life science companies in 2022, including 35 acquisitions by private equity firms, and 253 by strategics.

Akouos

Akouos, Inc.

645 Summer Street, Suite 200,
Boston, Massachusetts 02210
United States,
(857) 410-1818
www.akouos.com

Akouos is a precision genetic medicine company that develops gene therapies to restore, improve, and preserve physiologic hearing for people worldwide. Akouos's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate, AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. Akouos was founded in 2016 and is based in Boston, Massachusetts.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.